Prokidney appoints todd c. girolamo as general counsel

Winston-salem, n.c., march 28, 2022 (globe newswire) -- prokidney lp (prokidney), a leading clinical-stage cellular therapeutics company focused on therapies for chronic kidney disease (ckd) and prevention of end-stage renal disease (esrd) and need for dialysis, today announced the appointment of todd c. girolamo as general counsel.
PROK Ratings Summary
PROK Quant Ranking